{"created":"2023-06-20T14:29:06.707995+00:00","id":5115,"links":{},"metadata":{"_buckets":{"deposit":"21272649-04d3-46ff-857f-411f47d7632d"},"_deposit":{"created_by":14,"id":"5115","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"5115"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:00005115","sets":["223:225"]},"author_link":["46660","46661","777"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2022-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"21","bibliographicPageStart":"14","bibliographicVolumeNumber":"1","bibliographic_titles":[{"bibliographic_title":"Dokkyo Medical Journal"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":" 　Although several guidelines have been proposed for the physical management of patients with mental disorders, there are many differences among these guidelines, and it is necessary to review the literature for clinical implementation in Japan. The purpose of this study was to conduct a literature review using PubMed and Web of Science to examine the following serious physical risks that may affect the prognosis of patients with mental disorders: 1) abnormal glucose and lipid metabolism, 2) electrocardiographic abnormalities, 3) lithium poisoning, 4) severe drug eruption, and 5) malignant syndrome. There were some similarities in the monitoring plans for abnormal glucose and lipid metabolism, electrocardiographic abnormalities, and lithium poisoning. It was therefore assumed that a plan suitable for the actual situation in Japan could be formulated from these similarities. For severe drug eruptions, it is highly useful to provide information on these side effects as part of psychological education in addition to complying with the description in the package insert. For malignant syndromes, we suggest that it is important to consider the direction of basic interventions such as discontinuation of antipsychotics, systemic monitoring and management, infusion of fluids, and additional treatments as necessary.","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Dokkyo Medical Society"}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.51040/dkmj.1.1_14","subitem_relation_type_select":"DOI"}}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"2436-5211","subitem_source_identifier_type":"ISSN"}]},"item_10001_text_24":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"Department of Neuropsychiatry, Dokkyo Medical University"},{"subitem_text_value":"Department of Neuropsychiatry, Dokkyo Medical University"},{"subitem_text_value":"Department of Neuropsychiatry, Dokkyo Medical University"}]},"item_10001_text_33":{"attribute_name":"記事種別","attribute_value_mlt":[{"subitem_text_value":"Review Article"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yasui-Furukori, Norio","creatorNameLang":"en"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sugawara, Norio","creatorNameLang":"en"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shimoda, Kazutaka","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-04-20"}],"displaytype":"detail","filename":"DKMJ-1-1-5.pdf","filesize":[{"value":"103.5 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"DKMJ-1-1-Yasui-Furukori-Fulltext","url":"https://dmu.repo.nii.ac.jp/record/5115/files/DKMJ-1-1-5.pdf"},"version_id":"2c0915a1-f0ad-4a76-b580-d78e47472e31"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Monitoring","subitem_subject_scheme":"Other"},{"subitem_subject":"life expectancy","subitem_subject_scheme":"Other"},{"subitem_subject":"Mental disorders","subitem_subject_scheme":"Other"},{"subitem_subject":"Psychotropic drug","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Appropriate Monitoring May Affect the Life Expectancy of Patients with Mental Disorders in Japan: Literature Review on Guidelines for Serious Physical Risks","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Appropriate Monitoring May Affect the Life Expectancy of Patients with Mental Disorders in Japan: Literature Review on Guidelines for Serious Physical Risks"}]},"item_type_id":"10001","owner":"14","path":["225"],"publish_date":"2022-04-25","publish_status":"0","recid":"5115","relation_version_is_last":true,"title":["Appropriate Monitoring May Affect the Life Expectancy of Patients with Mental Disorders in Japan: Literature Review on Guidelines for Serious Physical Risks"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-06-20T14:45:20.416888+00:00"}